future therapies for aml: bispecifics and small molecule inhibitors
Published 5 years ago • 67 plays • Length 4:14Download video MP4
Download video MP3
Similar videos
-
1:02
bispecific agents: the future of aml and mds treatment?
-
2:26
insights into the future of aml therapy: the increasing use of targeted agents
-
1:12
the value of flt3 inhibitors in aml and focus for future trial designs
-
2:18
antibody therapies for aml and mds
-
3:37
the future of aml treatment
-
2:34
the evolution of the aml treatment paradigm
-
1:28
cd47 antibodies for the treatment of aml and mds: where is the field moving?
-
2:33
novel immunotherapies in aml and insights into the future of the treatment landscape
-
1:20
mimetics: the future of aml treatment?
-
1:19
new treatments for aml
-
2:11
the current role of immuno-oncology in aml and future outlooks
-
1:44
the future of aml therapy
-
2:49
maintenance therapy in aml: agents under investigation and future outlooks
-
1:41
the future of aml and mds diagnosis and treatment
-
2:18
future directions in aml: targeted therapies, antibody-radiation conjugates & new combinations
-
1:33
antibody-based therapy to treat aml: radioimmunoconjugates
-
2:58
evolution of the aml treatment paradigm
-
3:50
antibody-based therapy in aml: immunotoxins and bites
-
2:48
key targets and the future of immunotherapy in aml